News & Analysis on Clinical Trial Services & Contract Research And Development
According to a senior figure in the outsourcing industry, high content screening (HCS) is set to overtake current methods as the preferred technique of generating hits with the greatest interest coming from the oncology sector.
Most drug companies are not planning to increase the level of sales and marketing IT they outsource over the next 3-5 years - a sign that this niche segment may be bucking the wider pharmaceutical industry outsourcing trend.
While quickly gaining momentum, India's much hyped clinical research industry is still yet to take off.
Researchers have isolated a protein that appears to encourage cell movement when tumours begin to spread to other parts of the body opening up the way for a drug that could block the beginning of this dangerous process, or stop it once it starts.
Pfizer has revealed details of its new agreement with Transtech Pharma in which the two companies will focus on the receptor for advanced glycation end products (RAGE) with potential for use in treating Alzheimer's disease.
AstraZeneca have entered a deal with drug delivery device service provider Bang & Olufsen Medicom to develop a new electronic monitor that can tell whether patients are correctly taking their medication or not.